{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T17:19:06Z","timestamp":1721063946070},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2019,2,7]],"date-time":"2019-02-07T00:00:00Z","timestamp":1549497600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Sichuan Health and Family Planning Commission","award":["18PJ038"],"award-info":[{"award-number":["18PJ038"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Surg Int"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1007\/s00383-019-04448-7","type":"journal-article","created":{"date-parts":[[2019,2,7]],"date-time":"2019-02-07T01:08:28Z","timestamp":1549501708000},"page":"1027-1032","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Urinary nerve growth factor: a biomarker for detrusor overactivity in children? A meta-analysis and trail sequential analysis"],"prefix":"10.1007","volume":"35","author":[{"given":"Changkai","family":"Deng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiang","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianliang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maoxian","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xue","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,2,7]]},"reference":[{"key":"4448_CR1","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1016\/j.juro.2014.01.110","volume":"191","author":"PF Austin","year":"2014","unstructured":"Austin PF, Bauer SB, Bower W (2014) The standardization of terminology of lower urinary tract function in children and adolescents: update report from the Standardization Committee of the International Children\u2019s Continence Society. J Urol 191:1863\u20131865 e1813","journal-title":"J Urol"},{"key":"4448_CR2","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1002\/nau.22751","volume":"35","author":"PF Austin","year":"2016","unstructured":"Austin PF, Bauer SB, Bower W (2016) The standardization of terminology of lower urinary tract function in children and adolescents: Update report from the standardization committee of the International Children\u2019s Continence Society. Neurourol Urodyn 35:471\u2013481","journal-title":"Neurourol Urodyn"},{"key":"4448_CR3","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1038\/nrurol.2016.152","volume":"13","author":"I Franco","year":"2016","unstructured":"Franco I (2016) Overactive bladder in children. Nat Rev Urol 13:520\u2013532","journal-title":"Nat Rev Urol"},{"key":"4448_CR4","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.urology.2009.06.100","volume":"75","author":"JJ Stone","year":"2010","unstructured":"Stone JJ, Rozzelle CJ, Greenfield SP (2010) Intractable voiding dysfunction in children with normal spinal imaging: predictors of failed conservative management. Urology 75:161\u2013165","journal-title":"Urology"},{"key":"4448_CR5","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/S0022-5347(05)00416-7","volume":"175","author":"MP Fitzgerald","year":"2006","unstructured":"Fitzgerald MP, Thom DH, Wassel-Fyr C (2006) Childhood urinary symptoms predict adult overactive bladder symptoms. J Urol 175:989\u2013993","journal-title":"J Urol"},{"key":"4448_CR6","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1016\/j.juro.2008.06.054","volume":"180","author":"A Bael","year":"2008","unstructured":"Bael A, Lax H, de Jong TP (2008) The relevance of urodynamic studies for Urge syndrome and dysfunctional voiding: a multicenter controlled trial in children. J Urol 180:1486\u20131493","journal-title":"J Urol"},{"key":"4448_CR7","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/nrurol.2011.7","volume":"8","author":"R Cartwright","year":"2011","unstructured":"Cartwright R, Afshan I, Derpapas A (2011) Novel biomarkers for overactive bladder. Nat Rev Urol 8:139\u2013145","journal-title":"Nat Rev Urol"},{"key":"4448_CR8","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1002\/nau.20938","volume":"30","author":"SD Chung","year":"2011","unstructured":"Chung SD, Liu HT, Lin H (2011) Elevation of serum c-reactive protein in patients with OAB and IC\/BPS implies chronic inflammation in the urinary bladder. Neurourol Urodyn 30:417\u2013420","journal-title":"Neurourol Urodyn"},{"key":"4448_CR9","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1002\/nau.22832","volume":"35","author":"G Vijaya","year":"2016","unstructured":"Vijaya G, Cartwright R, Bhide A (2016) Reliability and validity of urinary nerve growth factor measurement in women with lower urinary tract symptoms. Neurourol Urodyn 35:944\u2013948","journal-title":"Neurourol Urodyn"},{"key":"4448_CR10","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1002\/nau.20599","volume":"28","author":"HT Liu","year":"2009","unstructured":"Liu HT, Kuo HC (2009) Urinary nerve growth factor levels are elevated in patients with overactive bladder and do not significantly increase with bladder distention. Neurourol Urodyn 28:78\u201381","journal-title":"Neurourol Urodyn"},{"key":"4448_CR11","doi-asserted-by":"publisher","first-page":"2270","DOI":"10.1016\/j.juro.2008.01.146","volume":"179","author":"HT Liu","year":"2008","unstructured":"Liu HT, Kuo HC (2008) Urinary nerve growth factor level could be a potential biomarker for diagnosis of overactive bladder. J Urol 179:2270\u20132274","journal-title":"J Urol"},{"key":"4448_CR12","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1002\/nau.23011","volume":"36","author":"JF Pennycuff","year":"2017","unstructured":"Pennycuff JF, Schutte SC, Hudson CO (2017) Urinary neurotrophic peptides in postmenopausal women with and without overactive bladder. Neurourol Urodyn 36:740\u2013744","journal-title":"Neurourol Urodyn"},{"key":"4448_CR13","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1007\/s00192-013-2104-0","volume":"24","author":"S Rachaneni","year":"2013","unstructured":"Rachaneni S, Arya P, Latthe P (2013) Urinary nerve growth factor: a biomarker of detrusor overactivity? A systematic review. Int Urogynecol J 24:1603\u20131609","journal-title":"Int Urogynecol J"},{"key":"4448_CR14","doi-asserted-by":"publisher","first-page":"8609","DOI":"10.4238\/2014.April.14.14","volume":"13","author":"HC Qu","year":"2014","unstructured":"Qu HC, Yan S, Zhang XL (2014) Urinary nerve growth factor levels could be a biomarker for overactive bladder symptom: a meta-analysis. Genet Mol Res 13:8609\u20138619","journal-title":"Genet Mol Res"},{"key":"4448_CR15","doi-asserted-by":"publisher","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","volume":"6","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6:e1000097","journal-title":"PLoS Med"},{"key":"4448_CR16","doi-asserted-by":"publisher","first-page":"359","DOI":"10.2147\/CLEP.S66677","volume":"6","author":"AV Margulis","year":"2014","unstructured":"Margulis AV, Pladevall M, Riera-Guardia N (2014) Quality assessment of observational studies in a drug-safety systematic review, comparison of two tools: the Newcastle-Ottawa Scale and the RTI item bank. Clin Epidemiol 6:359\u2013368","journal-title":"Clin Epidemiol"},{"key":"4448_CR17","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s12874-017-0315-7","volume":"17","author":"J Wetterslev","year":"2017","unstructured":"Wetterslev J, Jakobsen JC, Gluud C (2017) Trial sequential analysis in systematic reviews with meta-analysis. BMC Med Res Methodol 17:39","journal-title":"BMC Med Res Methodol"},{"key":"4448_CR18","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1002\/jrsm.1104","volume":"5","author":"E Kulinskaya","year":"2014","unstructured":"Kulinskaya E, Wood J (2014) Trial sequential methods for meta-analysis. Res Synth Methods 5:212\u2013220","journal-title":"Res Synth Methods"},{"key":"4448_CR19","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1002\/sim.4088","volume":"30","author":"JP Higgins","year":"2011","unstructured":"Higgins JP, Whitehead A, Simmonds M (2011) Sequential methods for random-effects meta-analysis. Stat Med 30:903\u2013921","journal-title":"Stat Med"},{"key":"4448_CR20","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.jpurol.2012.06.003","volume":"9","author":"T Oktar","year":"2013","unstructured":"Oktar T, Kocak T, Oner-Iyidogan Y (2013) Urinary nerve growth factor in children with overactive bladder: a promising, noninvasive and objective biomarker. J Pediatr Urol 9:617\u2013621","journal-title":"J Pediatr Urol"},{"key":"4448_CR21","first-page":"2690","volume":"13","author":"K Ozdemir","year":"2016","unstructured":"Ozdemir K, Dincel N, Berdeli A (2016) Can urinary nerve growth factor and brain-derived neurotrophic factor be used in the diagnosis and follow-up of voiding dysfunction in children? Urol J 13:2690\u20132696","journal-title":"Urol J"},{"key":"4448_CR22","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1007\/s11845-014-1162-8","volume":"184","author":"A Korzeniecka-Kozerska","year":"2015","unstructured":"Korzeniecka-Kozerska A, Wasilewska A (2015) Urinary nerve growth factor in patients with detrusor overactivity. Ir J Med Sci 184:737\u2013743","journal-title":"Ir J Med Sci"},{"key":"4448_CR23","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.urology.2017.01.021","volume":"103","author":"S Fukui","year":"2017","unstructured":"Fukui S, Aoki K, Morizawa Y (2017) Urinary nerve growth factor can predict therapeutic efficacy in children with overactive bladder. Urology 103:214\u2013217","journal-title":"Urology"},{"key":"4448_CR24","first-page":"e69","volume":"12","author":"HC Kuo","year":"2010","unstructured":"Kuo HC, Liu HT, Chancellor MB (2010) Can urinary nerve growth factor be a biomarker for overactive bladder?. Rev Urol 12:e69\u2013e77","journal-title":"Rev Urol"},{"key":"4448_CR25","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1111\/j.1464-410X.2012.11672.x","volume":"111","author":"JH Seth","year":"2013","unstructured":"Seth JH, Sahai A, Khan MS (2013) Nerve growth factor (NGF): a potential urinary biomarker for overactive bladder syndrome (OAB)? BJU Int 111:372\u2013380","journal-title":"BJU Int"},{"key":"4448_CR26","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1007\/s00192-014-2424-8","volume":"25","author":"SW Kim","year":"2014","unstructured":"Kim SW, Im YJ, Choi HC (2014) Urinary nerve growth factor correlates with the severity of urgency and pain. Int Urogynecol J 25:1561\u20131567","journal-title":"Int Urogynecol J"},{"key":"4448_CR27","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1038\/nrurol.2012.178","volume":"9","author":"P Ochodnicky","year":"2012","unstructured":"Ochodnicky P, Cruz CD, Yoshimura N (2012) Neurotrophins as regulators of urinary bladder function. Nat Rev Urol 9:628\u2013637","journal-title":"Nat Rev Urol"},{"key":"4448_CR28","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1111\/j.1464-410X.2010.09585.x","volume":"107","author":"HT Liu","year":"2011","unstructured":"Liu HT, Chen CY, Kuo HC (2011) Urinary nerve growth factor in women with overactive bladder syndrome. BJU Int 107:799\u2013803","journal-title":"BJU Int"},{"key":"4448_CR29","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1016\/S0929-6646(10)60133-7","volume":"109","author":"HT Liu","year":"2010","unstructured":"Liu HT, Chen CY, Kuo HC (2010) Urinary nerve growth factor levels in overactive bladder syndrome and lower urinary tract disorders. J Formos Med Assoc 109:862\u2013878","journal-title":"J Formos Med Assoc"},{"key":"4448_CR30","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1111\/j.1464-410X.2009.08380.x","volume":"103","author":"HT Liu","year":"2009","unstructured":"Liu HT, Chancellor MB, Kuo HC (2009) Decrease of urinary nerve growth factor levels after antimuscarinic therapy in patients with overactive bladder. BJU Int 103:1668\u20131672","journal-title":"BJU Int"},{"key":"4448_CR31","doi-asserted-by":"publisher","first-page":"118 e111","DOI":"10.1016\/j.jpurol.2015.09.015","volume":"12","author":"G Ergin","year":"2016","unstructured":"Ergin G, Kibar Y, Ebiloglu T (2016) The role of urinary nerve growth factor for the diagnosis and assessment of the biofeedback success in children with dysfunctional voiding. J Pediatr Urol 12:118 e111\u2013e116","journal-title":"J Pediatr Urol"}],"container-title":["Pediatric Surgery International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00383-019-04448-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00383-019-04448-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00383-019-04448-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,6]],"date-time":"2020-02-06T19:14:02Z","timestamp":1581016442000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00383-019-04448-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,7]]},"references-count":31,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["4448"],"URL":"https:\/\/doi.org\/10.1007\/s00383-019-04448-7","relation":{},"ISSN":["0179-0358","1437-9813"],"issn-type":[{"value":"0179-0358","type":"print"},{"value":"1437-9813","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,7]]},"assertion":[{"value":"25 January 2019","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2019","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors have no relevant financial relationships to the article to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}